FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
It's a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an initial rejection from the FDA...
It's a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an initial rejection from the FDA...
It costs a lot more to buy a house today than it did just a few years ago. And that expense starts with the down...
Lennar’s stock got chopped down Tuesday after a Raymond James analyst backed away from his longtime bullish call on the home builder — citing margin...
Deal documents show company wants to “kneecap competitors and dominate the market,” one Federal Trade Commission official says.
If your mother had Alzheimer’s disease at any age, your chances of getting it are higher, according to a recent study in JAMA Neurology.
Shares of Novo Nordisk and Eli Lilly & Co. dropped early Tuesday after President Joe Biden and Sen. Bernie Sanders took aim at obesity and...
The U.S. stock market just scored a gangbusters first half of the year. If history is a guide, Wall street could be in for another...
Chicago Federal Reserve Bank President Austan Goolsbee on Tuesday made the case for a cut in interest rates in coming months, saying that maintaining the...
NeuroSense Therapeutics Ltd.’s stock rose 6.5% Tuesday, as analysts cheered data from the biotech’s late-stage trial of a treatment for the fatal disease amyotrophic lateral...